Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizures, Focal”

251 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 251 results

Large-scale testing (Phase 3)Study completedNCT00988429
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 653
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Large-scale testing (Phase 3)Study completedNCT00744731
What this trial is testing

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 403
Testing effectiveness (Phase 2)Study completedNCT00416195
What this trial is testing

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Co., Ltd. 48
Testing effectiveness (Phase 2)WithdrawnNCT00567424
What this trial is testing

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline
Not applicableEnrolling By InvitationNCT07353918
What this trial is testing

Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy

Who this might be right for
Epilepsy (Treatment Refractory)Epilepsy Comorbidities
Carilion Clinic 6
Early research (Phase 1)Active Not RecruitingNCT06899230
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Who this might be right for
Drug Resistant EpilepsyFocal Seizure
iQure Australia Pty Ltd 72
Testing effectiveness (Phase 2)Study completedNCT00938431
What this trial is testing

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Who this might be right for
Epilepsy
UCB Pharma 47
Not applicableUnknownNCT05248269
What this trial is testing

Thermocoagulation in Drug Resistant Focal Epilepsy

Who this might be right for
EpilepsySeizures, FocalEpilepsy Intractable+1 more
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 75
Not applicableLooking for participantsNCT06388161
What this trial is testing

Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology

Who this might be right for
EpilepsyEncephalitis Autoimmune
Shen Chun-Hong 300
Not applicableStudy completedNCT03531008
What this trial is testing

Human Epilepsy Project 2: Resistant Focal Seizures Study

Who this might be right for
EpilepsyBrain DiseasesCentral Nervous System Diseases+2 more
Epilepsy Foundation of America 157
Testing effectiveness (Phase 2)Study completedNCT00465517
What this trial is testing

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Who this might be right for
Partial EpilepsyCatamenial Epilepsy
Marinus Pharmaceuticals 147
Large-scale testing (Phase 3)Study completedNCT00603473
What this trial is testing

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 92
Not applicableLooking for participantsNCT06241924
What this trial is testing

Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement

Who this might be right for
Parkinson DiseaseEpilepsy
University Hospital, Bordeaux 30
Not applicableStudy completedNCT00001489
What this trial is testing

Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism

Who this might be right for
EpilepsyEpilepsy, Complex Partial
National Institute of Neurological Disorders and Stroke (NINDS) 20
Testing effectiveness (Phase 2)Study completedNCT00236847
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60
Not applicableNot Yet RecruitingNCT07343609
What this trial is testing

Predictive Value of Seizure Frequency at Onset for Long-Term Seizure Control

Who this might be right for
Newly Diagnosed Epilepsy With Focus on Seizure Frequency at Onset and Long-term Seizure Control
Assiut University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05067634
What this trial is testing

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 140
Not applicableTemporarily pausedNCT04099342
What this trial is testing

Enhanced Spatial Targeting in ECT Utilizing FEAST

Who this might be right for
Treatment Resistant Depression
University of Minnesota 20
Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Next Page